Galapagos (GLPG) Earnings Date & Reports

Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

GLPG is expected to report earnings to fall 132.78% to -9 cents per share on April 23

Q1'25

Est.

$-0.10

Q4'24

Beat

by $0.02

Q3'24

Est.

$-0.82

Q2'24

Missed

by $0.01

Q1'24

Beat

by $0.47

The last earnings report on February 12 showed earnings per share of 30 cents, beating the estimate of 28 cents. With 252.01K shares outstanding, the current market capitalization sits at 1.61B.

View a ticker or compare two or three

Compare

GLPG